Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1.
- 1Medizinisches Versorgungszentrum MKG-Chirurgie, Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
- 2Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Abstract
Background/aim
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome. Characteristic tumors associated with NF1 can be traced to derivatives of the neural crest. Tumors of the sheath cells of peripheral nerves (neurofibromas) are particularly common in NF1. NF1 patients have an increased risk of developing malignant peripheral nerve sheath tumors (MPNSTs). These lesions primarily occur along the trunk and extremities. This report aims to expand the diagnostic spectrum of soft tissue tumors in NF1.Case report
A male patient with NF1 diagnosed in early childhood and a history of repeated surgical treatment for a facial plexiform neurofibroma (PNF) developed a rapidly growing, firm, protruding mass near the right shoulder joint over several months. Clinical examination and magnetic resonance imaging suggested a PNF; however, the biological nature of the lesion could not be determined conclusively. The tumor was surgically excised, and the postoperative course was uneventful. Histopathological examination revealed an intramuscular myxoma of the periarticular shoulder region. No recurrence was observed during two years of follow-up.Conclusion
Myxomas are not among the characteristic tumors of NF1. It appears that the development of a sporadic myxoma in NF1 is very rare. In this case, the findings and symptoms resembled those of a nodular PNF. Only surgical removal and histological examination could reveal the true biology of the lesion in this case.
Related
- Consensus recommendations for neurofibromatosis type 1 management in Asia Pacific
- Ruptured vertebral artery-origin aneurysm causing mediastinal compression and massive hemothorax in neurofibromatosis type 1
- Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1
- Aortic valve replacement in a patient with neurofibromatosis type 1: surgical considerations and perioperative management
- Melanoma in an Unlikely Guise: Diagnostic Challenges of a Solid–cystic Popliteal Mass in Neurofibromatosis Type 1
BibTeX
@article{friedrich2026intramuscular,
title = {{Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1.}},
author = {Reinhard E Friedrich and Catena Kresbach and Christian Hagel},
journal = {Cancer diagnosis \& prognosis},
year = {2026},
month = nov,
doi = {10.21873/cdp.10604},
url = {https://europepmc.org/article/MED/42968946},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1.
AU - Reinhard E Friedrich
AU - Catena Kresbach
AU - Christian Hagel
PY - 2026
DA - 2026/11/01
JO - Cancer diagnosis & prognosis
DO - 10.21873/cdp.10604
UR - https://europepmc.org/article/MED/42968946
AB - Background/aim Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome. Characteristic tumors associated with NF1 can be traced to derivatives of the neural crest. Tumors of the sheath cells of peripheral nerves (neurofibromas) are particularly common in NF1. NF1 patients have an increased risk of developing malignant peripheral nerve sheath tumors (MPNSTs). These lesions primarily occur along the trunk and extremities. This report aims to expand the diagnostic spectrum of soft tissue tumors in NF1.Case report A male patient with NF1 diagnosed in early childhood and a history of repeated surgical treatment for a facial plexiform neurofibroma (PNF) developed a rapidly growing, firm, protruding mass near the right shoulder joint over several months. Clinical examination and magnetic resonance imaging suggested a PNF; however, the biological nature of the lesion could not be determined conclusively. The tumor was surgically excised, and the postoperative course was uneventful. Histopathological examination revealed an intramuscular myxoma of the periarticular shoulder region. No recurrence was observed during two years of follow-up.Conclusion Myxomas are not among the characteristic tumors of NF1. It appears that the development of a sporadic myxoma in NF1 is very rare. In this case, the findings and symptoms resembled those of a nodular PNF. Only surgical removal and histological examination could reveal the true biology of the lesion in this case.
SN - 2732-7787
ER -